Alkem Laboratories Q1 Results
- BSE: 539523
- NSE: ALKEM
- ISIN: INE540L01014
- Sector: Biotechnology & Drugs
BSE
5,536.05
-94.50 (-1.68%)
-94.50 (-1.68%)Volume2.64 K
Updated: Mon 10 Aug, 2026 | 15:50:01
NSE
5,598.50-21.50 (-0.38%)
-21.50 (-0.38%)Volume82.54 K
Updated: Mon 10 Aug, 2026 | 15:14:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Alkem Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2,706.84 | 3,326.66 | -5.52% | 2,503.66 | 8.12% |
| Depreciation/ Amortization | 87.68 | 105.76 | -22.06% | 80.48 | 8.95% |
| Operating Income | 664.30 | 276.66 | 138.27% | 528.16 | 25.78% |
| Net Income | 664.26 | 236.46 | 117.18% | 545.16 | 21.85% |
| Other Operating Expenses Total | 767.68 | 1,125.96 | -10.40% | 744.96 | 3.05% |
| Net Income Before Taxes | 770.60 | 422.28 | 94.73% | 619.36 | 24.42% |
| Total Revenue | 3,371.14 | 3,603.32 | 7.23% | 3,031.82 | 11.19% |
| Selling/ General/ Admin Expenses Total | 693.25 | 712.10 | 12.48% | 602.27 | 15.11% |
| Diluted Normalized EPS | 54.62 | 26.49 | 113.56% | 45.60 | 19.79% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.